Second oral antiviral for COVID-19 on PBS broadens options for GPs
This comes as experts rule out routine use of sotrovimab against circulating subvariants and a new hybrid variant, Deltacron, emerges in Australia
A second oral antiviral for treating patients with COVID-19 at high risk of disease progression will be PBS listed from 1 May, the Federal Government says.
GPs will be able to write a script for nirmatrelvir–ritonavir (Paxlovid), and patients can fill it at their local pharmacy, Minister for Health Greg Hunt says.
The Pfizer combination therapy has been available through the National Medical Stockpile but will now be available on a script for adults with mild-to-moderate COVID-19 who are older than 65 and meet
